Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TAFAMIDIS Cause Wrong technique in product usage process? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Wrong technique in product usage process have been filed in association with TAFAMIDIS (Vyndamax). This represents 0.3% of all adverse event reports for TAFAMIDIS.

28
Reports of Wrong technique in product usage process with TAFAMIDIS
0.3%
of all TAFAMIDIS reports
2
Deaths
9
Hospitalizations

How Dangerous Is Wrong technique in product usage process From TAFAMIDIS?

Of the 28 reports, 2 (7.1%) resulted in death, 9 (32.1%) required hospitalization, and 1 (3.6%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does TAFAMIDIS Cause?

Death (2,553) Dyspnoea (608) Off label use (571) Cardiac failure (444) Fatigue (438) Fall (372) Malaise (301) Hypoacusis (298) Atrial fibrillation (296) Asthenia (256)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which TAFAMIDIS Alternatives Have Lower Wrong technique in product usage process Risk?

TAFAMIDIS vs TAFAMIDIS MEGLUMINE TAFAMIDIS vs TAFASITAMAB TAFAMIDIS vs TAFASITAMAB-CXIX TAFAMIDIS vs TAFINLAR TAFAMIDIS vs TAFLUPROST

Related Pages

TAFAMIDIS Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process TAFAMIDIS Demographics